SpaMedica expands private brand as NHS cataract volumes continue to decline

SpaMedica has reported another year of reduced earnings as the NHS continued attempts to rein in spending on independent ophthalmology provision. Revenue for the year ended 31 December 2025 came in at £279.6m – broadly flat on the prior year’s £281.6m. The specialist ophthalmology provider said increased private patient activity and growth in NHS YAG,…